Anzeige
Mehr »
Login
Donnerstag, 05.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 04.02.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.02.Pliant Therapeutics, Inc.: Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis266Bexotegrast (PLN-74809) at 320 mg was well tolerated over 12 weeks of treatment with no drug-related severe or serious adverse events; No safety concerns identified across all dose cohorts Bexotegrast...
► Artikel lesen
04.02.China Medical System Holdings Ltd.: China Medical System (00867) Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro276SHENZHEN, CHINA, Feb. 03, 2024 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 2 February 2024, the Group through its wholly-owned subsidiary...
► Artikel lesen
04.02.World Vapers' Alliance: WVA Condemns FCTC COP10's Exclusion of Consumers and Misguided Harm Reduction Policies905PANAMA CITY, Panama, Feb. 04, 2024 (GLOBE NEWSWIRE) -- As the 10th Session of the Conference of the Parties (COP10) to the WHO Framework Convention on Tobacco Control convenes, the World Vapers' Alliance...
► Artikel lesen